METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS

The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the J...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	JAYANTH, Jayanthy, MAYER, Peter T, MACHADO DE LACERDA, Ana Paula, JUNGERWIRTH, Steven, PANGAN, Aileen L, ENEJOSA, Jose Jeffrey V, OTHMAN, Ahmed, BORCHARDT, Thomas B, ROBINSON, Anne M, KLÜNDER, Ben, MULHERN, Mathew M, SHEIKH, Ahmad Y, MOHAMED, Mohamed-Eslam, NORDSTROM, Fredrik Lars, THAKKAR, Roopal B, MARROUM, Patrick J, ALLIAN, Ayman D
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the JAK1 inhibitor to induce clinical remission and/or endoscopic improvement of the Crohn's disease, followed by administration of at least one maintenance dose of the JAK1 inhibitor thereafter. In other embodiments, the present disclosure is directed to methods for treating ulcerative colitis using a JAK1 inhibitor.